The Deal
Tuesday, November 24, 
1:43 pm

Entries tagged "Actelion"

GSK in $2.7B deal for sleeping drug

GlaxoSmithKline plc agreed Monday to pay Actelion Ltd. as much as Sfr2.735 billion ($2.74 billion) including milestone fees for the rights to develop and market the Swiss biotechnology firm's experimental sleep disorder drug almorexant. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Actelion." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: Cisco Systems' Hooper talks about how transactions have transformed the company's business.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Loan-to-buy

By Steven Miller, Standard & Poor's

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.